Yahoo
Kuala Lumpur - Delayed Quote MYR

Duopharma Biotech Berhad (7148.KL)

1.1100 -0.0100 (-0.89%)
At close: October 30 at 4:42:42 PM GMT+8
View in AlphaSpace Currency in MYR All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
929,408
931,692
813,695
704,727
696,717
Cost of Revenue
545,846
568,555
512,157
436,401
416,899
Gross Profit
383,562
363,137
301,538
268,326
279,818
Operating Expense
231,025
229,345
200,887
185,513
187,398
Operating Income
152,537
133,792
100,651
82,813
92,420
Net Non Operating Interest Income Expense
-17,708
-18,883
-20,627
-15,447
-8,059
Pretax Income
134,296
114,909
80,024
63,267
84,851
Tax Provision
32,091
27,446
17,379
10,622
14,739
Net Income Common Stockholders
102,205
87,463
62,645
52,645
70,112
Diluted NI Available to Com Stockholders
102,205
87,463
62,645
52,645
70,112
Basic EPS
0.11
0.09
0.07
0.05
0.07
Diluted EPS
0.11
0.09
0.07
0.05
0.07
Basic Average Shares
962,367.9270
961,942
962,288.7860
958,513
948,308
Diluted Average Shares
962,367.9270
961,942
962,288.7860
958,513
948,308
Total Operating Income as Reported
152,004
133,792
100,651
78,714
92,910
Rent Expense Supplemental
--
--
--
--
2,231
Total Expenses
776,871
797,900
713,044
621,914
604,297
Net Income from Continuing & Discontinued Operation
102,205
87,463
62,645
52,645
70,112
Normalized Income
102,610.6358
87,463
62,645
56,055.8122
69,707.1152
Interest Income
5,968
5,870
5,965
2,750
1,521
Interest Expense
23,086
24,753
26,592
17,680
9,099
Net Interest Income
-17,708
-18,883
-20,627
-15,447
-8,059
EBIT
157,382
139,662
106,616
80,947
93,950
EBITDA
202,154
185,284
152,008
123,997
130,147
Reconciled Cost of Revenue
545,846
568,555
512,157
436,401
416,899
Reconciled Depreciation
44,772
45,622
45,392
43,050
36,197
Net Income from Continuing Operation Net Minority Interest
102,205
87,463
62,645
52,645
70,112
Total Unusual Items Excluding Goodwill
-533
--
1,431
-4,099
490
Total Unusual Items
-533
--
1,431
-4,099
490
Normalized EBITDA
202,687
185,284
152,008
128,096
129,657
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
-127.3642
0
0
-688.1878
85.1152
12/31/2022 - 7/19/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: